The risk-benefit task of research ethics committees: An evaluation of current approaches and the need to incorporate decision studies methods

BMC Medical Ethics

Volumn 13, Issue 1, 2012, Pages

  Bernabe, Rosemarie D L C ^a   Van Thiel, Ghislaine J M W ^a   Raaijmakers, Jan A M ^b   Van Delden, Johannes J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GLAXOSMITHKLINE   (Netherlands)

Author keywords

Component analysis; Decision theory; Ethics committee; IRB; Net risk test; Risk benefit assessment

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); DECISION MAKING; ETHICS; HUMAN; INTERPERSONAL COMMUNICATION; METHODOLOGY; PROFESSIONAL STANDARD; RESEARCH ETHICS; RISK ASSESSMENT;

CLINICAL TRIALS AS TOPIC; COMMUNICATION; DECISION MAKING; ETHICS COMMITTEES, RESEARCH; ETHICS, RESEARCH; HUMANS; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 84862196770     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-13-6     Document Type: Article

References (17)

1. Assessing and comparing potential benefits and risks of harm. King NM, Churchill LR, The Oxford textbook of clinical research ethics Oxford University Press, New York, Emanuel E, Grady C, Crouch RA, Lie RA, Miller FG, Wendler D, 2008 514 26
2. Ethical and Policy issues in Research Involving Human Participants. US National Bioethics Advisory Commission, 2001
3. Westra AE, de Beufort ID, The merits of procedure-level risk-benefit assessment Ethics and Human Research, IRB 2011
4. Aven T, Risk analysis: asssessing uncertainties beyond expected values and probabilities Wiley, Chichester 2008
5. Vose D, Risk analysis: a quantitative guide John Wiley & Sons, Chichester 3 2008
6. European Network and Information Security Agency. Risk assessment. European Network and Information Security Agency 2012 Available from: http://www.enisa.europa.eu/act/rm/cr/risk-management-inventory/rm-process/ risk-assessment
7. Evaluating benefits and harms in clinical research. Miller P, Weijer C, Principles of Health Care Ethics, Second Edition Wiley & Sons, Ashcroft RE, Dawson A, Draper H, McMillan JR, 2007
8. When are research risks reasonable in relation to anticipated benefits? Weijer C, Miller PB, Nat Med 2004 10 6 570 573 10.1038/nm0604-570 15170195
9. When are research risks reasonable in relation to anticipated benefits? Weijer C, J Law Med Ethics 2000 28 344 361 10.1111/j.1748-720X.2000.tb00686.x 11317427
10. Assessing research risks systematically: the net risks test. Wendler D, Miller FG, J Med Ethics 2007 33 8 481 486 10.1136/jme.2005.014043 17664310
11. A framework for risk-benefit evaluations in biomedical research. Rid A, Wendler D, Kennedy Inst Ethics J 2011 June 21 2 141 179 10.1353/ken.2011.0007
12. European Medicines Agency - Committee for Medicinal Products for Human Use. Reflection paper on benefit-risk assessment methods in the context of the evaluation of marketing authorization applications of medicinal products for human use 2008
13. Mussen F, Salek S, Walker S, Benefit-risk appraisal of medicines John Wiley & Sons, Chichester 2009
14. Baron J, Thinking and deciding Cambridge University Press, New York 4 2008
15. Decision analysis: the ethical approach to most health decision making. Dowie J, Principles of Health Care Ethics John Wiley & Sons, Ashcroft RE, Dawson A, Draper H, McMillan JR, 2007 577 83
16. Council for International Organizations of Medical Sciencess Working Group IV. Benefit-risk balance for marketed drugs: evaluating safety signals 1998 22942967
17. Risk-benefit assessment in medical research- critical review and open questions. Rid A, Wendler D, Law, Probability Risk 2010 9 151 177 10.1093/lpr/mgq006